The most common reasons for patients without intravenous t‐PA in DAPT and aspirin monotherapy groups were mild symptoms (35.30%), rapid improvement of stroke symptoms (14.61%), and patient or family refusal (17.04%). Here, PLAT is linked to stroke disorder.